Home › Graft-Versus-Host Disease › Michigan
Graft-Versus-Host Disease clinical trials in Michigan
5 studies for Graft-Versus-Host Disease are looking for participants at sites in Michigan.
Cities in Michigan
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
- The University of Michigan Cancer Center, Ann Arbor
RecruitingObservational study
36 Months · All sexes · Updated Nov 9, 2026 · NCT05866302A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Michigan, Ann Arbor
- Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06615050A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Barbara Ann Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
- Henry Ford Hospital, Detroit
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Feb 24, 2026 · NCT04886726A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.